MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The impact of Deep Brain Stimulation for Parkinson’s disease on Quality of Life

    M. Schiess, S. Bick, J-P. Azulay, S. Palfi, T. Witt, A. López Ríos, F. Farrokhi, B. Bretscher, G. Hilleren, T. Weaver (Houston, USA)

    Objective: To evaluate the long-term outcomes in Quality of Life (QoL) for patients with Parkinson’s disease (PwP) enrolled in a global, real-world device registry for…
  • 2024 International Congress

    Using LEAD-DBS to Identify the Optimal DBS Electrode in the Abbott Infinity System

    J. Karl, S. Dong, C. Taylor, N. Shetty, J. Rosenow, M. Nolt, L. Verhagen Metman (Chicago, USA)

    Objective: To determine whether the optimal electrode contact selected in Abbott deep brain stimulation (DBS) leads is the same using conventional versus image-guided programming (LEAD-DBS…
  • 2024 International Congress

    Impact of DBS STN on motor symptoms, postural instability, QoL in PD patients from the Belarusian population

    A. Buniak, S. Likhachev, V. Alexeyevets, V. Bayarchyk (Minsk, Belarus)

    Objective: To evaluate the efficiency of DBS STN in PD patients in Republican center of neurology and neurosurgery Background: Deep brain stimulation (DBS) of the…
  • 2024 International Congress

    Can Technology Improve Service Delivery and Patient Outcomes in a Parkinson’s Speech and Language Therapy Clinic?

    C. Meskill, C. Bartliff, J. O'Loughlin (Cork, Ireland)

    Objective: -       Determine if Telea, an online care platform, can aid in efficiently addressing caseload needs and quantify clinical time saved through…
  • 2024 International Congress

    Initiation of AT-HOME PD2, a Remote Observational Study of Parkinson’s Disease Clinical Trial Participants

    R. Schneider, A. Hoyt, R. Wilson, S. Mahes, C. Stevens, C. Tarolli, J. Adams, B. Valdovinos, K. Lizarraga, P. Auinger, S. Benvengo, M. Monje, E. Macklin, D. Weintraub, K. Biglan, A. Ascherio, A. Espay, C. Tanner, D. Novak, J. Beck, I. Shoulson, T. Simuni, S. Sieberts, E. Dorsey, M. Schwarzschild (Rochester, USA)

    Objective: To describe the design and initiation of a remote, long-term observational Parkinson’s disease (PD) study - Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease…
  • 2024 International Congress

    Reliability of Digital Measures in Parkinson’s Disease and Their Implications for Sample Size Calculations

    J. Lavine, A. Scotina, S. Haney, E. Izmailova, L. Omberg (New York, USA)

    Objective: Assess the reliability and measurement error of measures derived from digital health technologies (DHTs) in Parkinson’s Disease (PD) patients and estimate sample size for…
  • 2024 International Congress

    Wearable sensors and AI in Parkinson’s disease – How continuous symptom and treatment response monitoring can enable better clinical decision making – Interim results from an observational study

    M. Sander, S. Goh, S. Knapp, F. Pfister, S. Karie, K. Rou, S. Li, N. Jie, V. Zhi, L. Louis, C. Teng, L. Seng, A. Lok, T. Yaw, X. Zheyu, S. Min, M. Anish, P. Manharlal, L. Weishan, A. Ng (München, Germany)

    Objective: To investigate how continuous objective information on motor symptoms and treatment response combined with subjective patient reported insights can be used to optimize Parkinson’s…
  • 2024 International Congress

    Artificial Intelligence Opportunities for Diagnostics of Dementia via Speech (Brainphone Project)

    I. Khasanov, D. Khasanova (Kazan, Russian Federation)

    Objective: The aim of the clinical study was the assessment of efficiency of the screening diagnositics method for dementia by speech using AI-based technology (BRAINPHONE…
  • 2024 International Congress

    The first Indian patient with Hereditary Spastic Paraparesis type 42 due to a de novo SLC33A1 variant

    A. Agarwal, P. Sharma, D. Garg, A. Garg, M. Faruq, A. Srivastava (New Delhi, India)

    Objective: Hereditary Spastic Paraparesis (HSP) 42 is an autosomal dominant HSP caused by pathogenic mutations in the SLC33A1 gene. This subtype has been reported from a…
  • 2024 International Congress

    Autosomal recessive cerebellar ataxias: a Tunisian cohort of 168 patients

    L. Hlioui, R. Zouari, R. Amouri, MZ. Saied, D. Ben Mohamed, A. Rachdi, S. Ben Sassi (Tunis, Tunisia)

    Objective: The aim of our study is to describe epidemiological, clinical and paraclinical features of the different autosomal recessive cerebellar ataxias (ARCA) identified in our…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley